Relisys Medical Devices Limited Sustainability Profile
Relisys Medical Devices Limited, headquartered in India, is a prominent player in the medical device industry, specialising in innovative healthcare solutions. Founded in 1998, the company has established a strong presence in various operational regions, focusing on the development and manufacturing of high-quality medical devices. Relisys is renowned for its core products, which include advanced diagnostic equipment and life-saving devices, distinguished by their reliability and cutting-edge technology. The company has achieved significant milestones, positioning itself as a trusted name in the healthcare sector, with a commitment to enhancing patient care through its unique offerings. With a robust market presence, Relisys continues to contribute to the evolution of medical technology, ensuring better health outcomes globally.
DitchCarbon Score
How does Relisys Medical Devices Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Relisys Medical Devices Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Relisys Medical Devices Limited's reported carbon emissions
Relisys Medical Devices Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Relisys may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As the company operates within the medical devices sector, it is essential for them to consider implementing robust climate strategies to align with global sustainability trends and regulatory expectations. Without specific emissions data or reduction initiatives, Relisys Medical Devices Limited may face challenges in demonstrating its commitment to environmental responsibility and climate action.
How Carbon Intensive is Relisys Medical Devices Limited's Industry?
How Carbon Intensive is Relisys Medical Devices Limited's Location?
Relisys Medical Devices Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Relisys Medical Devices Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
